STAT+: Roche suffers a fresh blow as India’s Supreme Court allows generic sales of its pricey rare disease drug
In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which Roche sought to prevent a generic drug maker from selling a lower-cost version of